Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 1997

View Archived Issues

Novo Nordisk claims metabotropic glutamate receptor antagonists

Dual NK1/NK2 receptor antagonists from Rhone-Poulenc Rorer

Leukotriene antagonists claimed by Menarini

Calcium channel blockers disclosed by Warner-Lambert

Antibacterial mupirocin sulfamates from SmithKline Beecham

Anti-HIV agents from CNRS

FCE-29642A: a novel antiepileptic compound from Pharmacia & Upjohn

Pharmacia & Upjohn describes orally active anticonvulsants

Takeda claims melatonin agonists

PDE IV and/or TNF production inhibitors from Pfizer

Perindopril accelerates endothelial regrowth in animal model

Haemacure to begin pivotal trials of Hemaseel HMN

Abgenix, JT and GenPharm sign crosslicensing agreement for human MAb technologies

Cypros receives patent coverage for neuroprotective agents

Urologix's PMA for T3 System accepted for review

Gene Logic enters Alzheimer's disease gene discovery collaboration

FDA clears Faulding's generic captopril

Yewtaxan cleared for marketing in The Netherlands

Court rules in favor of Novopharm regarding generic ranitidine product

Onyx expands clinical trials of ONYX-015

Yamanouchi characterizes new vasopressin antagonist, YM-087

Positive phase III results reported for Centocor's Crohn's disease treatment

NIH researchers discover adult stem cells: Potential for nervous system repair

5-LO inhibitor not effective as monotherapy in active ulcerative colitis

Transmyocardial Revascularization phase II results reported

Nonoxynol-9 not effective for reducing HIV transmission

Tropisetron prevents vomiting following gynecological surgery

hCG potentially useful in fighting HIV

ProCyte reports results from hair growth trial

Antitumor activity of Ono-4007 related to TNF induction

University of Texas/Regeneron research finding covered under U.S. patent

NO-1886 increases HDL cholesterol by increasing LPL activity

Clinical efficacy and safety of Aphthasol reviewed

First launch for Zeneca's Zomig

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....